ALLEVIATION OF CISPLATIN INDUCED NEPHROTOXICITY IN ALBINO RATS BY ROOTS OF Catunaregam uliginosa
DOI:
https://doi.org/10.22159/ajpcr.2016.v9i6.13956Abstract
ABSTRACT:
Objective: To evaluate the nephroprotective effect of ethanolic extract of roots of Catunaregam ulginosa in cisplatin induced nephrotoxicity in albino rats.
Methodology: Ethanolic extract was prepared by hot extraction method and subjected to preliminary phytochemical studies. Based on acute toxicity studies nephroprotector was screened at two dose levels i.e., 200mg/kg bd wt and 400 mg/kg bd wt in both curative and prophylactic regimens. Cisplatin at a dose of 5mg/kg bd. wt was given intraperitoneally to induce nephrotoxicity. Nephroprotector activity was assessed by determining blood urea nitrogen (BUN), serum creatinine(SC), urinary total protein(UTP) and creatinine clearance. Antioxidant enzymes like super oxide dismutase (SOD), catalase (CAT), glutatathione reduced (GSH) activities and lipid peroxidation (LPO) levels were determined in renal tissue. Histological studies had been carried per se.
Results: Animals which received cisplatin exhibited significant increase in serum marker levels, increased urinary total protein excretion and reduced creatinine clearance. Further significant decrease in GSH, SOD, CAT and increase in LPO levels was observed. Ethanolic extract of roots of Catunaregam ulginosa reversed the effects induced by cisplatin in dose dependent manner in both curative and prophylactic regimens. Histological studies substantianed the above results.
Conclusion: The findings of the present study support the alleviation of cisplatin induced nephrotoxicity by the ethanolic extract of roots of Catunaregam ulginosa and thus validate its ethnomedicinal use.
Key words: Catunaregam ulginosa, Cisplatin, Nephrotoxicity, Lipid peroxidationDownloads
References
Lamer-Zarawska E. Biflavonoids in Juniperus L. Sp (Cupressaceae). Pol J Pharmacol Pharm 1975;27(1):81-7.
WHO. Traditional Medicine Strategy 2002-2005. Geneva: World Health Organization; 2002.
Tandon V, Kapoor B, Gupta BM. Herbal drug research in India: A trend analysis using IJP as a marker. Indian J Pharmacol 2004;36(2):9-100.
Pazhayattil GS, Shirali AC. Drug-induced impairment of renal function. Int J Nephrol Renovasc Dis 2014;7:457-68.
Hartmann JT, Fels LM, Knop S, Stolt H, Kanz L, Bokemeyer C. A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors. Invest New Drugs 2000;18(3):281-9.
Hartmann JT, Lipp HP. Toxicity of platinum compounds. Expert Opin Pharmacother 2003;4(6):889-901.
Luke DR, Vadiei K, Lopez-Berestein G. Role of vascular congestion in cisplatin-induced acute renal failure in the rat. Nephrol Dial Transplant 1992;7(1):1-7.
Arany I, Safirstein RL. Cisplatin nephrotoxicity. Semin Nephrol 2003;23(5):460-4.
Chetty KM, Sivaji K, Rao KT. Flowering Plants of Chittoor District. Andhra Pradesh, India: Student Offset Printers; 2008. p. 162.
Harbone JP. Phytochemical Methods: A Guide to Modern Technique of Plant Analysis. London: Chapman and Hall; 1973. p. 1-271.
Organization for Economic Cooperation and Development (OECD). Guideline 423 for Testing Chemicals. Paris: Organization for Economic Cooperation and Development (OECD); 2001. p. 1-14.
Godkar PB. Kidney function tests. In: Text Book of Medicinal Laboratory. Bombay: Bhalani Publishing House; 1994. p. 1022-8.
Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82(1):70-7.
Aebi H. Catalase. In: Bergmeyer HU, editor. Methods of Enzymatic Analysis. New York and London: Academic Press; 1974. p. 673-7.
Saggu H, Cooksey J, Dexter D, Wells FR, Lees A, Jenner P, et al. A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem 1989;53(3):692-7.
Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95(2):351-8.
Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin nephrotoxicity: A review. Am J Med Sci 2007;334(2):115-24.
Kuhlmann MK, Burkhardt G, Köhler H. Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol Dial Transplant 1997;12(12):2478-80.
Sastry J, Kellie SJ. Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine. Pediatr Hematol Oncol 2005;22(5):441-5.
Naziroglu M, Karaoglu A, Aksoy AO. Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology 2004;195(2-3):221-30.
Mora Lde O, Antunes LM, Francescato HD, Bianchi Mde L. The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats. Pharmacol Res 2003;47(6):517-22.
Antunes LM, Darin JD, Bianchi MD. Protective effects of vitamin c against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: A dose-dependent study. Pharmacol Res 2000;41(4):405-11.
Jose S, Adikay S. Effect of the ethanolic extract of Scoparia dulcis in cisplatin induced nephrotoxicity in wistar rats. Indian J Pharm Educ Res 2015;49 4 Suppl: s68-74.
Janakiraman M, Jayaprakash K. Nephroprotective potential of medicinal plants: A Review. Int J Sci Res 2015;4(9):543-7.
Ajith TA, Jose N, Janardhanan KK. Amelioration of cisplatin induced nephrotoxicity in mice by ethyl acetate extract of a polypore fungus, Phellinus rimosus. J Exp Clin Cancer Res 2002;21(2):213-7.
Mondi S, Kvsrg P, Jhansi D, Vijay R, Rao VU. Prophylactic and curative effect of ethanolic extract of Bassia malabarica bark against cisplatin induced nephrotoxicity. Asian J Pharm Clin Res 2014;7(4):143-6.
Ingale KG, Thakurdesai PA, Vyawahare NS. Protective effect of Hygrophila spinosa against cisplatin induced nephrotoxicity in rats. Indian J Pharmacol 2013;45(3):232-6.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
